Kolexia
Pavese Ida
Oncologie médicale
Hôpital Le Raincy Montfermeil
Montfermeil, France
40 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Urgences Carcinome pulmonaire à petites cellules COVID-19 Tumeurs hématologiques Délire avec confusion {{person.topmesh9.name}} {{person.topmesh10.name}}

Industries

MSD
3 collaboration(s)
Dernière en 2021
AstraZeneca
2 collaboration(s)
Dernière en 2020
Ipsen
1 collaboration(s)
Dernière en 2020
Lilly
1 collaboration(s)
Dernière en 2020

Dernières activités

Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer.
Cancers   11 février 2022
Time-dependent efficacy of checkpoint inhibitor nivolumab in metastatic lung cancer patients.
2021 ASCO Annual Meeting I   28 mai 2021
Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth.
Frontiers in oncology   19 novembre 2020
Circadian variation in nivolumab efficacy in patients with advanced non-small cell lung cancer.
2020 ASCO Annual Meeting I   25 mai 2020
Questions About Emergency Department Treatment of Patients With Solid Tumors and Hematological Malignant Neoplasms.
JAMA oncology   18 septembre 2019
Impact on treatment adherence, side effects control, patients QoL, and rehospitalization rate through new management of oral chemotherapy.
2018 ASCO Annual Meeting I   01 juin 2018
Patients with delirium and advanced solid cancer in the emergency department: A challenge for the emergency practitioner, oncologist, and intensivist.
Cancer   14 novembre 2016
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}